Green to Scale: Plant-Based Polymer for Efficient Adherent Cell Manufacturing From Small to Large Scale

As demand for adherent cell culture expands across Cell and Gene Therapies (CGT) and Advanced Therapy Medicinal Products (ATMPs), sustainable and scalable solutions are critical to meeting future manufacturing needs. This session will explore how innovative bioprocessing approaches can reduce environmental impact while enabling closed and connected processing in automated and GMP-compliant workflows.

Key discussion points include:

- Trends and challenges in scaling adherent cell culture for CGT and ATMP manufacturing

- Design innovations and use of renewable materials to optimise process efficiency and reduce lifecycle carbon emissions

- Performance of emerging sustainable systems, with practical examples including stem cells and HEK293 cells for CGT and viral vector production

- Strategies to accelerate time-to-market while minimising COGS and risks

Learn how next-generation technologies like CellScrew® are driving cost-efficient, sustainable, and scalable solutions for the future of CGT and ATMP manufacturing.